<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Lilly and Plaintiffs&#8217; Attorneys Enter Into an Agreement in Principle to Settle Majority of Zyprexa&#174; Product Liability Litigation</title>
	<atom:link href="http://www.gpwlaw.com/news/news/personal-injury/2005/06/09/lilly-and-plaintiffs-attorneys-enter-into-an-agreement-in-principle-to-settle-majority-of-zyprexa-product-liability-litigation/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.gpwlaw.com/news/news/personal-injury/2005/06/09/lilly-and-plaintiffs-attorneys-enter-into-an-agreement-in-principle-to-settle-majority-of-zyprexa-product-liability-litigation/</link>
	<description>Just another WordPress weblog</description>
	<lastBuildDate>Fri, 29 Jun 2007 13:38:59 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.1</generator>
	<item>
		<title>By: &#187; Zyprexa &#38; Diabetes (Olanzapine) &#187; Blog Archive GPWLaw News</title>
		<link>http://www.gpwlaw.com/news/news/personal-injury/2005/06/09/lilly-and-plaintiffs-attorneys-enter-into-an-agreement-in-principle-to-settle-majority-of-zyprexa-product-liability-litigation/comment-page-1/#comment-4</link>
		<dc:creator>&#187; Zyprexa &#38; Diabetes (Olanzapine) &#187; Blog Archive GPWLaw News</dc:creator>
		<pubDate>Mon, 23 Apr 2007 21:23:09 +0000</pubDate>
		<guid isPermaLink="false">http://www.gpwlaw.com/news/news/personal-injury/2005/06/09/lilly-and-plaintiffs-attorneys-enter-into-an-agreement-in-principle-to-settle-majority-of-zyprexa-product-liability-litigation/#comment-4</guid>
		<description>[...] Eli Lilly has already agreed to a Zyprexa settlement including some $700 Million to those injured by the drug. In September 2003, the FDA required changes to the Zyprexa warning label to clearly alert the risk of diabetes and hyperglycemia associated with the drug. [...]</description>
		<content:encoded><![CDATA[<p>[...] Eli Lilly has already agreed to a Zyprexa settlement including some $700 Million to those injured by the drug. In September 2003, the FDA required changes to the Zyprexa warning label to clearly alert the risk of diabetes and hyperglycemia associated with the drug. [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>
